# Tago, Inc.

- Location (FDA's records): Mchenry, IL
- FDA decisions: 8 (1983–1984): 8 510(k) clearances
- Product codes: MSJ (2), DAD (1), DHR (1), DCN (1), KTN (1), LKL (1), JHJ (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K841734: Tago Fiffu-Gen, Orosomucoid (Jun 1, 1984)
- K841265: Tago Diffu-Gen C-Reactive Protein (May 22, 1984)
- K834218: Diffu-Gen Apolipoprotein a-I Radial - (May 11, 1984)
- K840404: Diffu-Gen Haptoglobin Radial Immuno (Mar 9, 1984)
- K833129: Tago Diffu-Gen-Apolipoprotein B-100 (Nov 21, 1983)
- K830611: RA Screening Test (Mar 24, 1983)
- K830531: Mono Screening Test (Mar 17, 1983)
- K830156: HCG Screening Test (Feb 9, 1983)

Source page: https://510kreport.com/company/tago